Several nutritional pitfalls commonly occur when individuals begin GLP-1 therapy, potentially compromising health outcomes or treatment efficacy
Do not share your Ozempic pen with others, even if the needle has been changed
This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)
Your dose may need to go up over time
The possibility of obtaining high-purity crude products with short reaction times prompted the development of dedicated automated instrumentation, such as the peptide synthesizers produced by CEM and CSBio corporations
Oral Administration Clinical trials demonstrate that injectable tirzepatide produces more consistent week-to-week weight loss trajectories because blood levels remain stable throughout the dosing interval